Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
Tadej Battelino, Richard M Bergenstal, Angel Rodríguez, Laura Fernández Landó, Ross Bray, Zhentao Tong, Katelyn Brown
Topics & Concepts
MedicineInsulin degludecType 2 diabetesContinuous glucose monitoringInternal medicineDiabetes mellitusEndocrinologyBlood Glucose Self-MonitoringInsulinPhase (matter)CardiologyClinical trialPhases of clinical researchRandomized controlled trialContinuous infusionGlycemicMEDLINEDiabetes Management and ResearchDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins